Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy
Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…
Read more
Named profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma
Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…
Read more
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read more
Medicinal Mushroom Extracts: Product-Specific Oncology Evidence
Mushroom products differ by species, extracted fraction, standardization, contaminants, and evidence; the word mushroom does not identify a tested intervention.
Read more
Chinese Herbal Formulas: Identification, Quality, and Evidence Review
A named traditional formula can vary by translation, ingredient, species, processing, manufacturer, and practitioner modification, so exact identification comes before benefit or safety claims.
Read more
Yunnan Baiyao-Type Hemostasis Discussion: Preclinical Evidence Is Not Bleeding Control
Yunnan Baiyao is used anecdotally in veterinary bleeding plans, but formulation opacity and limited clinical evidence do not support relying on it to prevent or stop tumor hemorrhage.
Read more
Probiotics and Synbiotics During Cancer Treatment: Strain-Specific Evidence
Probiotic effects are strain-, combination-, product-, storage-, and condition-specific, and immune compromise changes the safety conversation.
Read more
Named profile Jing Tang Stasis Breaker: Veterinary Product ProfileRepresentative category illustration – no product packaging is shown.Jing Tang Stasis Breaker: Veterinary Product Profile
Jing Tang Stasis Breaker is a named herbal formula for Dogs and cats; the current manufacturer page also lists horses; manufacturer positioning must be kept separate from independent…
Read more
Named profile Jing Tang Max’s Formula: Veterinary Product ProfileRepresentative category illustration – no product packaging is shown.Jing Tang Max’s Formula: Veterinary Product Profile
Jing Tang Max's Formula is a named herbal formula for Dogs and cats; the current manufacturer page also lists horses; manufacturer positioning must be kept separate from independent…
Read more
Named profile Four Leaf Rover Turkey Tail Mushroom: Product ProfileRepresentative category illustration – no product packaging is shown.Four Leaf Rover Turkey Tail Mushroom: Product Profile
Four Leaf Rover Turkey Tail Mushroom is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.
Read more
Named profile Australian Pet Nutrition Immune Support: Veterinary Product ProfileRepresentative category illustration – no product packaging is shown.Australian Pet Nutrition Immune Support: Veterinary Product Profile
Australian Pet Nutrition Immune Support is a named branded product for Dogs and cats; manufacturer positioning is kept separate from independent clinical and regulatory evidence.
Read more
Named profile Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea SupportRepresentative category illustration – no product packaging is shown.Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea Support
crofelemer delayed-release tablets is covered as prescription antisecretory gastrointestinal medicine; supportive care, not antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more